High seroprotection rates achieved with two doses of Sci-B-Vac, a third-generation hepatitis B vaccine containing Pre-S1, Pre-S2, and S antigens April 9, 2019 | High seroprotection rates achieved with two doses of Sci-B-Vac, a third-generation hepatitis B vaccine containing Pre-S1, Pre-S2, and S antigens Conference: 2019 Annual Meeting of the European Association for the Study of the Liver (EASL) Date: April 9, 2019